Matinas BioPharma Holdings Income Statement (2013-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Revenue & cost
Revenue (Quarter)		-333.00		1.06M	1.06M	1.06M	0.38M	0.72M
Operating items
Research & Development (Quarter)	4.62M	4.24M	4.98M	4.13M	3.71M	3.87M	3.97M	3.56M	3.29M	3.67M	3.45M	3.37M	2.24M	2.38M	0.09M
Selling, General & Administrative (Quarter)	2.26M	2.47M	2.74M	2.86M	2.82M	2.68M	2.71M	2.60M	2.84M	2.22M	2.46M	2.47M	2.14M	1.66M	1.86M	1.84M	1.58M	1.60M	1.94M	1.55M
Restructuring Costs (Quarter)	0.03M	0.01M
Other Operating Expenses (Quarter)	-0.03M	-0.01M												4.43M		0.11M		-0.07M		-0.14M
Operating Expenses (Quarter)	6.88M	6.71M	7.72M	6.99M	6.53M	6.54M	6.68M	6.16M	6.13M	5.89M	5.90M	5.84M	4.38M	8.47M	1.95M	1.84M	1.58M	1.60M	1.94M	1.55M
Operating Income (Quarter)	-6.88M	-6.71M	-7.72M	-5.92M	-5.46M	-5.48M	-5.59M	-6.16M	-6.13M	-5.89M	-5.90M	-5.84M	-4.38M	-8.47M	-1.95M	-1.84M	-1.58M	-1.60M	-1.94M	-1.55M
EBIT (Quarter)	-6.88M	-6.71M	-7.72M	-5.92M	-5.46M	-5.48M	-5.59M	-6.16M	-6.13M	-5.89M	-5.90M	-5.84M	-4.38M	-8.47M	-1.95M	-1.84M	-1.58M	-1.60M	-1.94M	-1.55M
Non-operating items
Non Operating Investment Income (Quarter)		-470.00	1.73M			1.76M
Other Non Operating Income (Quarter)	0.04M	0.02M	0.01M	0.00M	988.00	0.09M	0.07M	0.10M	0.08M	0.09M	0.08M	0.12M	0.11M	-0.04M	-0.00M	-0.06M	0.04M	-0.24M	0.01M	-0.00M
Non Operating Income (Quarter)
Net income details
EBT (Quarter)	-13.02M	-37.74M	-8.48M	-11.42M	-10.95M	-39.87M	-6.66M	-7.20M	-7.17M	-5.89M	-6.85M	-9.72M	-5.33M	-8.50M	-1.97M	-2.11M	-1.85M	-1.71M	-1.94M	-1.56M
Profit After Tax (Quarter)	-6.89M	-6.47M	-5.98M	-5.92M	-5.46M	-2.84M	-5.51M	-6.06M	-6.05M	-5.18M	-5.74M	-5.64M	-4.22M	-8.43M	-1.66M	-5.25M	-1.53M	-1.29M	-1.92M	-1.33M
Income from Non-Controlling Interests (Quarter)
Income from Continuing Operations (Quarter)	-13.02M	-37.74M	-8.48M	-11.42M	-10.95M	-39.87M	-6.66M	-7.20M	-7.17M	-5.89M	-6.85M	-9.72M	-5.33M	-8.50M	-1.97M	-2.11M	-1.85M	-1.71M	-1.94M	-1.56M
Consolidated Net Income (Quarter)	-13.02M	-37.74M	-8.48M	-11.42M	-10.95M	-39.87M	-6.66M	-7.20M	-7.17M	-5.89M	-6.85M	-9.72M	-5.33M	-8.50M	-1.97M	-2.11M	-1.85M	-1.71M	-1.94M	-1.56M
Income towards Parent Company (Quarter)	-13.02M	-37.74M	-8.48M	-11.42M	-10.95M	-39.87M	-6.66M	-7.20M	-7.17M	-5.89M	-6.85M	-9.72M	-5.33M	-8.50M	-1.97M	-2.11M	-1.85M	-1.71M	-1.94M	-1.56M
Preferred Dividend Payments (Quarter)		201.00
Net Income towards Common Stockholders (Quarter)	-6.84M	-6.70M	-5.98M	-5.92M	-5.46M	-3.63M	-6.66M	-7.20M	-7.17M	-5.89M	-6.85M	-9.72M	-4.28M	-8.43M	-1.66M	-2.11M	-2.15M	-5.25M	-1.92M	-1.33M
Additional items
EPS (Basic) (Quarter)	-1.59	-1.59	-1.38	-1.37	-1.26	-0.84	-1.53	-1.66	-1.65	-1.36	-1.57	-1.95	-0.85	-1.73	-0.33	-0.41	-0.40	-0.96	-0.30	-0.21
EPS (Diluted) (Quarter)				-1.37	-1.26	-0.84	-1.53	-1.66	-1.65	-1.36	-1.57	-1.95	-0.85	-1.73	-0.33	-0.41	-0.40	-0.96	-0.30	-0.21
Shares Outstanding (Quarter)	4.30M	4.20M	4.33M	4.34M	4.34M	4.34M	4.35M	4.35M	4.35M	4.35M	4.35M	4.99M	5.04M	4.87M	5.09M	5.09M	5.44M	5.47M	6.41M	6.41M
Shares Outstanding (Diluted) (Quarter)				4.34M	4.34M	4.34M	4.35M	4.35M	4.35M	4.35M	4.35M	4.99M	5.04M	4.87M	5.09M	5.09M	5.44M	5.47M	6.41M	6.41M
Shares Outstanding (Entity) (Quarter)	4.32M	4.33M	4.34M	4.34M	4.34M	4.35M	4.35M	4.35M	4.35M	4.35M	4.35M	5.02M	5.09M	5.09M	5.09M	5.09M	5.90M	6.41M	6.41M	6.41M
EBITDA (Quarter)	-6.88M	-6.71M	-7.72M	-5.92M	-5.46M	-5.48M	-5.59M	-6.16M	-6.13M	-5.89M	-5.90M	-5.84M	-4.38M	-8.47M	-1.95M	-1.84M	-1.58M	-1.60M	-1.94M	-1.55M
Interest Expenses (Quarter)	6.15M	31.02M	0.75M	5.50M	5.49M	34.39M	1.08M	1.04M	1.04M	0.00M	0.94M	3.88M	0.94M	0.03M	0.02M	0.27M	0.27M	0.11M	0.01M	0.01M

Research Tools

Datasets

Plans

Developers

Matinas BioPharma Holdings MTNB Income Statement (2013-2026)

Research Tools

Datasets

Plans

Developers

Matinas BioPharma Holdings MTNB Income Statement (2013-2026)

Create an account

Sign In

Reset Password